Literature DB >> 19949364

Predicting severe bacterial infections in well-appearing febrile neonates: laboratory markers accuracy and duration of fever.

Silvia Bressan1, Barbara Andreola, Francesca Cattelan, Tiziana Zangardi, Giorgio Perilongo, Liviana Da Dalt.   

Abstract

OBJECTIVES: To assess the diagnostic accuracy of white blood cell count (WBC), absolute neutrophil count (ANC), and C-reactive protein (CRP) in detecting severe bacterial infections (SBI) in well-appearing neonates with early onset fever without source (FWS) and in relation to fever duration.
METHODS: An observational study was conducted on previously healthy neonates 7 to 28 days of age, consecutively hospitalized for FWS from less than 12 hours to a tertiary care Pediatric Emergency Department, over a 4-year period. Laboratory markers were obtained upon admission in all patients and repeated 6 to 12 hours from admission in those with normal values on initial determination. Sensitivity, specificity, positive and negative likelihood ratios, and receiver operating characteristic analysis were carried out for primary and repeated laboratory examinations.
RESULTS: Ninety-nine patients were finally studied. SBI was documented in 25 (25.3%) neonates. Areas under receiver operating characteristic curves were 0.78 (95% CI, 0.69-0.86) for CRP, 0.77 (95% CI, 0.67-0.85) for ANC and 0.59 (95% CI, 0.49-0.69) for WBC. Sixty-two patients presented normal laboratory markers on initial determination. Of these, 58 successfully underwent repeated blood examination at >12 hours from fever onset. Five of them had an SBI. The area under curve calculated for repeated laboratory tests showed better values, respectively of 0.99 (95% CI, 0.92-1) for CRP, 0.85 (95% CI, 0.73-0.93) for ANC and 0.79 (95% CI, 0.66-0.88) for WBC.
CONCLUSIONS: In well-appearing neonates with early onset FWS, laboratory markers are more accurate and reliable predictors of SBI when performed after >12 hours of fever duration. ANC and especially CRP resulted better markers than the traditionally recommended WBC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19949364     DOI: 10.1097/INF.0b013e3181b9a086

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Interference of Vaccine Derived Polio Viruses with Diagnosis of Enteroviral Diseases in Neonatal Period.

Authors:  Mohammad Saeed Sasan; Alireza Ataei Nakhaei; Abdolvahab Alborzi; Mazyar Ziyaeyan
Journal:  J Clin Diagn Res       Date:  2016-11-01

2.  Bacterial meningitis in febrile young infants acutely assessed for presumed urinary tract infection: a systematic review.

Authors:  Elisa Poletto; Lorenzo Zanetto; Roberto Velasco; Liviana Da Dalt; Silvia Bressan
Journal:  Eur J Pediatr       Date:  2019-08-31       Impact factor: 3.183

3.  Obstetric Risk Factors and Serological Characteristics of Early-Onset Neonates Bacterial Infections.

Authors:  Yuejiao Wang; Qi Chen; Shixia Xu; Shuang Chao
Journal:  Front Surg       Date:  2022-06-20

4.  Procalcitonin levels predict acute kidney injury and prognosis in acute pancreatitis: a prospective study.

Authors:  Hua-Lan Huang; Xin Nie; Bei Cai; Jiang-Tao Tang; Yong He; Qiang Miao; Hao-Lan Song; Tong-Xing Luo; Bao-Xiu Gao; Lan-Lan Wang; Gui-Xing Li
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

5.  Incidence and Outcomes of Infections Caused by Multidrug-Resistant Enterobacteriaceae in Children, 2007-2015.

Authors:  Sharon B Meropol; Allison A Haupt; Sara M Debanne
Journal:  J Pediatric Infect Dis Soc       Date:  2018-02-19       Impact factor: 3.164

6.  The Value of the "Lab-Score" Method in Identifying Febrile Infants at Risk for Serious Bacterial Infections.

Authors:  Diana Aniela Moldovan; Maria Despina Baghiu; Alina Balas; Sorana Teodora Truta
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-03-01

7.  C-reactive protein for diagnosing late-onset infection in newborn infants.

Authors:  Jennifer Valeska Elli Brown; Nicholas Meader; Jemma Cleminson; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2019-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.